EUVIMEDEUVIMED entdecken
Crossref

Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumonia

Claire Roger iD, Bernard Allaouchiche, Daniel Quintão De Moraes, Olivier Ulrich Feudjio, Bob-Valéry Occean, Arnaud Friggeri iD, Jean-Yves Lefrant, Laurent Muller, Dominique Breilh iD

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Claire Roger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anesthesia and Critical Care, Pain and Emergency Medicine, UR-UM103 IMAGINE, Univ Montpellier, Nîmes University Hospital, Montpellier, Fr…. Hauptthemen laut MEDLINE: Community-Acquired Infections, Anti-Bacterial Agents, Cephalosporins, Lung. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Advanz Pharma Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal antimicrobial drug exposure in the lung is required for ensuring successful treatment of community-acquired pneumonia (CAP). Little is known about the intrapulmonary pharmacokinetics (PK) of ceftobiprole when administered by continuous infusion (CI).

Objective

To determine the PK of high doses (3 g/day) CI of ceftobiprole in the plasma and epithelial lining fluid (ELF) in mechanically ventilated patients with CAP.

Methods

Patients receiving a CI of ceftobiprole (2.5 g daily after a 0.5 g bolus loading dose) for the treatment of severe CAP were eligible. Plasma and ELF samples were collected over 3 days of therapy. Concentrations were analysed by HPLC-UV, and population PK modelling was conducted using Monolix™. Monte Carlo simulations were performed to estimate the probability of target attaining a free ELF concentration of 100% of time above MIC.

Results

Twelve patients, 2 female, median (IQR) age 67 (58–71), were enrolled with 108 plasma and 12 ELF concentrations included in the population analysis. The median (min–max) lung penetration ratio was 30 (15–45) % after 3 doses of ceftobiprole. In the Monte Carlo simulations, higher doses given as CI (3 g/day) may be necessary for MICs up to 2 mg/L in patients with normal renal function. The final PK model using a 4 × MIC plasma target may help to approximate ELF target attainment.

Conclusions

The use of high doses of ceftobiprole given by CI may be necessary to achieve PK/pharmacodynamic targets in ELF in critically ill patients with CAP and normal renal function, especially when less susceptible pathogen is suspected or identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsAnti-Bacterial AgentsCephalosporinsLungPneumonia, BacterialHumansFemaleCritical IllnessMaleAgedMiddle AgedInfusions, IntravenousPlasmaMonte Carlo MethodMicrobial Sensitivity TestsChromatography, High Pressure LiquidCommunity-Acquired Pneumonia

Substanzen

Anti-Bacterial AgentsCephalosporinsceftobiprole

Autor:innen und Institutionen

  • Division of Anesthesia and Critical Care, Pain and Emergency Medicine, UR-UM103 IMAGINE, Univ Montpellier, Nîmes University Hospital, Montpellier, France.
  • Centre Hospitalier Lyon-Sud, Service de Réanimation, Hospices Civils de Lyon, Pierre-Bénite 69310, France.
  • Université Claude Bernard, Lyon 1, Lyon, France.
  • Pulmonary and Cardiovascular Aggression in Sepsis APCSe, UPSP 2021.A101, Université de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Marcy l'Étoile F-69280, France.
  • ADLIN Science, Paris, France.
  • Department of Epidemiology, Medical Statistics and Public Health, Nîmes University Hospital, Montpellier University, Nîmes, France.

ORCID-Profile: Claire Roger, Arnaud Friggeri, Dominique Breilh

Förderung

  • Advanz Pharma Company

Zitieren

APA

Roger, C., Allaouchiche, B., Quintão De Moraes, D., Ulrich Feudjio, O., Occean, B. V., Friggeri, A., Lefrant, J. Y., Muller, L., & Breilh, D. (2025). Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumonia. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf267

Vancouver

Roger C, Allaouchiche B, Quintão De Moraes D, Ulrich Feudjio O, Occean BV, Friggeri A, et al. Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumonia. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf267

BibTeX
@article{Roger2025,
  author = {Roger, Claire and Allaouchiche, Bernard and Quintão De Moraes, Daniel and Ulrich Feudjio, Olivier and Occean, Bob-Valéry and Friggeri, Arnaud and Lefrant, Jean-Yves and Muller, Laurent and Breilh, Dominique},
  title = {Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumonia},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf267}
}
Kostenlos starten →